Novel antiarthritic mechanisms of Azelaic acid against CFA-induced arthritis in rats by modulating pro- and anti-inflammatory cytokines network
Inflammopharmacology · 2024-08 · 32 (4) · 2445-2462
DOI: 10.1007/s10787-024-01512-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, online erschienen am 25.06.2024. Verfasst von Nabeela Tabassum Sial und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, 40100, Pakistan. Hauptthemen laut MEDLINE: Cytokines, Arthritis, Experimental, Anti-Inflammatory Agents, Freund's Adjuvant. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
An immunologic system attacking the body's own tissues is a hallmark of autoimmune disorders, which encompass a wide range of unique conditions. Numerous essential biologic functions, including the regulation of the immune system, inflammation, cell division, and tissue repair, are carried out by cytokines. Natural compounds are an effective treatment for autoimmune illnesses by modulation of inflammatory cytokines and infiltration of leukocytes into the inflamed tissue. Here, anti-arthritic study was carried out using oral administration of Azelaic acid (AzA) for 28 days with doses (20, 40, and 80 mg/kg) in Complete Freund's Adjuvant (CFA) induced arthritis model. AzA ameliorated the adjuvant-induced arthritis by decreasing arthritic score, paw volume, improved body-weight alterations and serum levels of PGE2, 5-LOX and anti-ccp. AzA showed significant down regulation of NF-κB, COX-II, TNF-α, IL-17, IL-1β, IL-6, and up regulation of IL4 and IL10. Hemoglobin and RBCs count remarkably increased and ESR, CRP, platelets, WBCs levels markedly reduced in post treatment. In addition, the weakened SOD (superoxide dismutase), Catalase (CAT), Glutathione (GSH) activity and the increased levels of malondialdehyde (MDA) were all reversed by AzA treatment. And showed improved radiographical and histologic alterations in the structure of the joints. Molecular docking studies targeting COX-II, iNOS, TNF-α, 5-LOX, IL4, IL10, IL-6, and IL-17 establish a correlation between theoretical and experimental results. Results showed that AzA inhibit pro-inflammatory cytokines (COX-II, TNF-α, 5-LOX, IL-17, NF-κB, IL-1β, and IL-6) and increase anti-inflammatory cytokines, which supported the anti-arthritic and immunomodulatory potential of AzA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, 40100, Pakistan.
- Institute of Pharmacy, Lahore College for Women University, Lahore, Pakistan.
- Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, 40100, Pakistan. abdul.malik@uos.edu.pk.
- Department of Pharmaceutical Sciences, Government College University, Lahore, Pakistan.
- Institute of Chemistry, University of Sargodha, Sargodha, Pakistan.
Zitieren
APA
Sial, N. T., Malik, A., Iqbal, U., Mehmood, M. H., & Rehman, M. F. U. (2024). Novel antiarthritic mechanisms of Azelaic acid against CFA-induced arthritis in rats by modulating pro- and anti-inflammatory cytokines network. Inflammopharmacology, 32(4), 2445-2462. https://doi.org/10.1007/s10787-024-01512-0
Vancouver
Sial NT, Malik A, Iqbal U, Mehmood MH, Rehman MFU. Novel antiarthritic mechanisms of Azelaic acid against CFA-induced arthritis in rats by modulating pro- and anti-inflammatory cytokines network. Inflammopharmacology. 2024;32(4):2445-2462. doi:10.1007/s10787-024-01512-0
BibTeX
@article{Sial2024,
author = {Sial, Nabeela Tabassum and Malik, Abdul and Iqbal, Urooj and Mehmood, Malik Hassan and Rehman, Muhammad Fayyaz Ur},
title = {Novel antiarthritic mechanisms of Azelaic acid against CFA-induced arthritis in rats by modulating pro- and anti-inflammatory cytokines network},
journal = {Inflammopharmacology},
year = {2024},
volume = {32},
number = {4},
pages = {2445--2462},
doi = {10.1007/s10787-024-01512-0}
}
EUVIMED